Overview

Veterinary Vaccines Market Introduction

Veterinary Vaccines Market is estimated to value over USD 12.3 billion by 2027 end and register a CAGR of over 6.9% during the forecast period 2020 to 2027.

Rising incidences of livestock epidemics, increasing population of livestock and rising prevalence of zoonotic diseases are steering the global veterinary vaccines market growth. Rising awareness with regards to the commercial vaccines is responsible for the increasing adoption worldwide.

This market is one of the lucrative alternatives of investments seeking attention and investments from both non-government and government key players. The shifting emphasis on healthy animal husbandry and an increasing number of pet owners are other important factors boosting the market proliferation. The intervention of the government in channel distribution whereas, it is affecting the overall profits incurred by the manufacturers of the veterinary vaccines.

Attenuated vaccines segment dominated the market owing to advantages, for instance, enhanced long-term prevention and improved effectivity. Cattle vaccinations held the largest global veterinary vaccines market share owing to the rise in the insistence for safe and effective animal products. The companion animal vaccines are currently proliferating due to an increase in the number of pet ownerships across the world. The North American region subjugated the market in 2018. Rising animal product commercialization and increasing awareness regarding the health of animals are prime reasons for the region’s domination over the forecast period. The Asia Pacific region is predicted to exhibit rapid augmentation during the forecast timeframe due to faster adoption of animal vaccines for better animal health and high-quality food products.

Key market players included in the global veterinary vaccines industry are Zoetis, Merck Animal Health, Boehringer Ingelheim, Elanco, Ceva, Virbac, Vetoqunol, Phibro Animal Health, Hester, Hipra, Biologika, Biogenesis Bago, Tianjin Ringpu, China Animal Husbandry, Jinyu Bio-Technology.

Global Veterinary Vaccines Market Segmentation:

By Type

Porcine Vaccines
Poultry Vaccines
Livestock Vaccines
Bovine Vaccines
Small Ruminant Vaccines
Companion Animal Vaccines
Canine Vaccines
Feline Vaccines
Aquaculture Vaccines
Other Animal Vaccines

By Disease

Porcine
Poultry
Livestock
Bovine
Small Ruminants
Companion Animals
Canine
Feline
Aquaculture

By Technology

Live Attenuated Vaccines
Inactivated Vaccines
Toxoid Vaccines
Recombinant Vaccines
Other Vaccines

By Region

Europe
North America
Asia Pacific
Rest of the World

FutureWise Key Takeaways:

Growth prospects
SWOT analysis
Key trends
Key data-points affecting market growth

Objectives of the Study:

To provide with an exhaustive analysis on the global veterinary vaccines market by type, by disease, by technology and by region
To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
To evaluate and forecast micro-markets and the overall market
To predict the market size, in key regions (along with countries)— North America, Europe, Asia Pacific and the rest of the world
To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers and expansions
Profiling of companies to evaluate their market shares, strategies, financials and core competencies

Flexible Delivery Model:

We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
The customization Mobility Care offered are free of charge with purchase of any license of the report
You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com